NCT00369733View on ClinicalTrials.gov

STAAR-3 Clinical Study

PHASE4CompletedINTERVENTIONAL

Enrollment

443

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

March 31, 2004

Study Completion Date

May 31, 2004

Conditions

Chronic Kidney DiseaseChronic Renal InsufficiencyKidney DiseasePre-dialysisPre-ESRD

Interventions

DRUG

Darbepoetin alfa

Darbepoetin alfa adminstered SC every other week to acheive a Hb not to exceed 12 g/dL

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Amgen

INDUSTRY